Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention

被引：94
|
作者：
Lange, Naomi F. [1 ,2 ]
Radu, Pompilia [1 ]
Dufour, Jean-Francois [1 ]
机构：
[1] Inselspital Bern, Univ Clin Visceral Surg & Med, Bern, Switzerland
[2] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷 / 05期
关键词：
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Hepatocellular carcinoma; Prevention; Lifestyle; Diet; Physical activity; Coffee; Alcohol; Aspirin; Statins; Probiotics; FATTY LIVER-DISEASE; RANDOMIZED CONTROLLED-TRIAL; HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; VIRAL-HEPATITIS; RISK-FACTORS; WEIGHT-LOSS; MEDITERRANEAN DIET; DIABETIC-PATIENTS; ALCOHOL-DRINKING;
D O I：
10.1016/j.jhep.2021.07.025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing. Preventive strategies are needed to counteract this trend. In this review, we provide an overview of the evidence on preventive strategies in NAFLD-associated HCC. We consider the impact of lifestyle factors such as weight loss, physical activity, smoking, dietary patterns and food items, including coffee and alcohol, on both HCC and NAFLD/NASH. Furthermore, evidence on chemopreventive treatments, including aspirin, antidiabetic treatments and statins is summarised. The role of adjuvant therapies for tertiary prevention of HCC is briefly reviewed. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
引用
收藏
页码：1217 / 1227
页数：11
相关论文
共 50 条
  • [21] Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma
    Castellana, Marco
    Donghia, Rossella
    Lampignano, Luisa
    Castellana, Fabio
    Zupo, Roberta
    Sardone, Rodolfo
    De Pergola, Giovanni
    Giannelli, Gianluigi
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (20)
  • [22] Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis
    Tian, Yuan
    Mok, Myth T. S.
    Yang, Pengyuan
    Cheng, Alfred S. L.
    CANCERS, 2016, 8 (08):
  • [23] Metabolic-immunoregulatory role of CCRK-mTOR signaling in NAFLD-associated hepatocellular carcinoma
    Tang, Wenshu
    Zhou, Jingying
    Yang, Weiqin
    Feng, Yu
    Mok, Myth
    Cheng, Alfred Sze
    CANCER RESEARCH, 2019, 79 (13)
  • [24] ROLE OF NAFLD-ASSOCIATED GENETIC VARIANTS ON RENAL FUNCTION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Di Costanzo, A.
    Baratta, F.
    D'Erasmo, L.
    Umbro, I.
    Colantoni, A.
    Cocomello, N.
    Pastori, D.
    Arca, M.
    Angelico, F.
    Del Ben, M.
    ATHEROSCLEROSIS, 2022, 355 : E280 - E281
  • [25] NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders
    Anna Simona Sasdelli
    Lucia Brodosi
    Giulio Marchesini
    Current Hepatology Reports, 2016, 15 (2) : 103 - 112
  • [26] Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
    Turchinovich, Andrey
    Baranova, Ancha
    Drapkina, Oksana
    Tonevitsky, Alexander
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [27] Prevention of colorectal cancer: Diet, chemoprevention, and lifestyle
    Marshafl, James R.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2008, 37 (01) : 73 - +
  • [28] BREAST CANCER PREVENTION: LIFESTYLE CHANGES AND CHEMOPREVENTION
    Lambrechts, S.
    Decloedt, J.
    Neven, P.
    ACTA CLINICA BELGICA, 2011, 66 (04) : 283 - 292
  • [29] The Role of Gut-Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
    Song, Qian
    Zhang, Xiang
    BIOMEDICINES, 2022, 10 (03)
  • [30] Histone Deacetylase 8 Is a Novel Chromatin Modulator in NAFLD-Associated Hepatocarcinogenesis
    Tian, Yuan
    To, Ka F.
    Lai, Paul B. S.
    Cheung, Yue S.
    Wong, Vincent W. S.
    Chan, Henry L. Y.
    Cheng, Alfred S. L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (01) : 219 - 219
12345